Your browser doesn't support javascript.
loading
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer.
van Soest, R J; Nieuweboer, A J M; de Morrée, E S; Chitu, D; Bergman, A M; Goey, S H; Bos, M M; van der Meer, N; Hamberg, P; de Wit, R; Mathijssen, R H J.
Afiliación
  • van Soest RJ; Department of Urology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl.
  • Nieuweboer AJ; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
  • de Morrée ES; Department of Urology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
  • Chitu D; Department of Biostatistics, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
  • Bergman AM; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Goey SH; Department of Internal Medicine, Tweesteden Hospital, Tilburg, The Netherlands.
  • Bos MM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands.
  • van der Meer N; Department of Clinical Trial Center, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
  • Hamberg P; Department of Internal Medicine, St Franciscus Gasthuis and Prostate Cancer Center, Rotterdam, The Netherlands.
  • de Wit R; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
  • Mathijssen RH; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
Eur J Cancer ; 51(17): 2562-9, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26278646
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptores Androgénicos / Terapia Molecular Dirigida / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptores Androgénicos / Terapia Molecular Dirigida / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido